Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop

Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learni...

Full description

Saved in:
Bibliographic Details
Published in:Asia-Pacific journal of clinical oncology 2022-12, Vol.18 (6), p.650-659
Main Authors: Roberts, Natasha A., Cubitt, Annette, Lindsay, Dianne, Bury, Kimberley, Dixon, Jacqueline, Gebbie, Chantal, Hawkins, Cheryl‐Ann, Major, Taylor, Jenkins‐Marsh, Sue, Morris‐Smith, Bernadette, Poxton, Melanie, Richmond, Sue, Smith, Delaine, Stoneley, Adam, Thaker, Darshit A., Wilson, Elizabeth, Woollett, Anne, Underhill, Craig, Sabesan, Sabe
Format: Article
Language:English
Subjects:
Australia
clinical trial
Clinical trials
COVID-19
Oncology
telemedicine
teletrial
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction The Australasian Teletrial Model was piloted in co‐funded sites across Australia. The purpose was to extend the reach of clinical trials using telemedicine to improve equity and access to this treatment pathway for oncology patients. Experts across Australia gathered to share the learnings of implementation so that future directions can be effective and sustainable. Methods The 1‐day workshop was attended in person and virtually. Attendees were invited to analyze and disseminate the results. Recordings from the presentations were coded independently by three researchers and synthesized. The results were sent to the authorship team for further review to build consensus on the findings in three drafts. Results Four key themes were identified: “Being on the Same Page,” “Building Foundations,” “Key Roles in Teletrials,” and “Incentives.” Although there were many successes that were accelerated by the COVID‐19 pandemic, there is work still to be done. Conclusion The Australasian Teletrial Model has been identified as acceptable and feasible. Future directions need to continue to work on streamlining regulatory processes, implementation and monitoring, and build knowledge to further build networks across Australia.
ISSN:1743-7555
1743-7563
DOI:10.1111/ajco.13737